Tumor cells expressing PD-L1 interact with PD-1, inhibiting T cell migration, proliferation, and the secretion of anti-tumor cytokines, consequently weakening the body’s anti-tumor immunity (Zhu et al., 2021). Here, CD274 is linked to neoplasm.